...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith AGM Dec 15

Zenith AGM is December 15, according to SEDAR filing. Both RVX and Zenith AGMs on the same date again.

Share
New Message
Please login to post a reply